Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

SulzerMedica USA

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 1
Lead investments 0
Key employees Soon

Areas of investment

  • Health Care
  • Health Diagnostics
  • Medical Device
  • Therapeutics
Summary

The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Upper Lakes Growth Capital, St. Paul Venture Capital. In the next rounds fund is usually obtained by St. Paul Venture Capital, Upper Lakes Growth Capital, Pequot Capital.

The important activity for fund was in 2002. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 5 - 10 millions dollars.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Disc Dynamics. Among the most successful fund investment fields, there are Therapeutics, Medical Device.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of SulzerMedica USA:
There are no funds here. If we find new data, we will add it here.
Typical Co-investors
SulzerMedica USA is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after SulzerMedica USA:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Amylin Pharmaceuticals California, San Diego, United States
Aurora Private Equity Aberdeen, Scotland, United Kingdom
CCC Marketing Japan, Tokyo
Discover PreAccelerator Lusaka, Lusaka, Zambia
Equus Total Return,Inc. Houston, Texas, United States
Forum Media Group Bavaria, Germany, Merching
Fujikura Japan, Koto
HealthQuest Capital California, Menlo Park, United States
KBW Ventures California, San Mateo, United States
Media Future Japan, Tokyo
ProQuest Ann Arbor, Michigan, United States
Riordan, Lewis & Haden Equity Partners California, Los Angeles, United States
RockBridge Capital Partners Columbus, Ohio, United States
Silicon Alley Seed Investors New York, New York, United States
STC Ventures Dubai, United Arab Emirates
The Provco Group Bryn Mawr, Pennsylvania, United States
The Singer Group Maryland, Reisterstown, United States
University of Melbourne Australia, Melbourne, Victoria
Venture Capital Guiding Fund of Songjiang China, Shanghai
WRV Capital California, Menlo Park, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent SulzerMedica USA?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 9M
Peak activity year 2002
Lead investments 0
Group Appearance index 1.00
Crunchbase icon

Content report

The following text will be sent to our editors: